Explore › Outcome › neuropathy development
Outcome

neuropathy development

Also known as: Association between serum biomarkers (glutamine, NGF, VEGF) and neuropathy development or glutamine benefit
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Serum glutamine measurement1
conditions
vincristine-induced peripheral neuropathy1
populations
Children1
studys
PMC55983521

Findings (27)

None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →
None
null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352
Finding details → · Paper → · Graph →

Papers (1)